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Biophysical characterization of layer-by-layer synthesis of aptamer-drug 
microparticles for enhanced cell targeting. 
ABSTRACT 
Targeted delivery of drug molecules to specific cells in mammalian systems demonstrates 
a great potential to enhance the efficacy of current pharmaceutical therapies. 
Conventional strategies for pharmaceutical delivery are often associated with poor 
therapeutic indices and high systemic cytotoxicity, and this result in poor disease 
suppression, low surviving rates, and potential contraindication of drug formulation. The 
emergence of aptamers has elicited new research interests into enhanced targeted drug 
delivery due to their unique characteristics as targeting elements. Aptamers can be 
engineered to bind to their cognate cellular targets with high affinity and specificity, and 
this is important to navigate active drug molecules and deliver sufficient dosage to 
targeted malignant cells. However, the targeting performance of aptamers can be 
impacted by several factors including endonuclease‐mediated degradation, rapid renal 
filtration, biochemical complexation, and cell membrane electrostatic repulsion. This has 
subsequently led to the development of smart aptamer‐immobilized biopolymer systems 
as delivery vehicles for controlled and sustained drug release to specific cells at effective 
therapeutic dosage and minimal systemic cytotoxicity. This article reports the synthesis 
and in vitro characterization of a novel multi‐layer co‐polymeric targeted drug delivery 
system based on drug‐loaded PLGA‐Aptamer‐PEI (DPAP) formulation with a stage‐wise 
delivery mechanism. A thrombin‐specific DNA aptamer was used to develop the DPAP 
system while Bovine Serum Albumin (BSA) was used as a biopharmaceutical drug in the 
synthesis process by ultrasonication. Biophysical characterization of the DPAP system 
showed a spherical shaped particulate formulation with a unimodal particle size 
distribution of average size ∼0.685 µm and a zeta potential of +0.82 mV. The DPAP 
formulation showed a high encapsulation efficiency of 89.4 ± 3.6%, a loading capacity of 
17.89 ± 0.72 mg BSA protein/100 mg PLGA polymeric particles, low cytotoxicity and a 
controlled drug release characteristics in 43 days. The results demonstrate a great 
promise in the development of DPAP formulation for enhanced in vivo cell targeting. © 
2017 American Institute of Chemical Engineers Biotechnol. 
